Gujarat Terce Laboratories Ltd — Important, 29-05-2026: Company Update

The company's Board has approved the re-appointment of Mr. Aalap Prajapati as Managing Director & CEO for a five-year term, effective from October 28, 2026, to October 27, 2031. This decision, following the Nomination and Remuneration Committee's proposal, awaits shareholder approval at the upcoming Annual General Meeting. Mr. Prajapati, with over 15 years of pharmaceutical experience, plays a key role in driving operational efficiency and long-term business development for the company. He is the son of Mr. Natwarbhai Prajapati, a Whole-Time Director.